- Home
- TTEK vs CORT Comparison
TTEK vs CORT Comparison
Compare TTEK & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTEK
- CORT
- Stock Information
- Founded
- TTEK 1966
- CORT 1998
- Country
- TTEK United States
- CORT United States
- Employees
- TTEK N/A
- CORT N/A
- Industry
- TTEK Military/Government/Technical
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- TTEK Consumer Discretionary
- CORT Health Care
- Exchange
- TTEK Nasdaq
- CORT Nasdaq
- Market Cap
- TTEK 9.2B
- CORT 7.1B
- IPO Year
- TTEK 1991
- CORT N/A
- Fundamental
- Price
- TTEK $34.94
- CORT $77.56
- Analyst Decision
- TTEK Buy
- CORT Strong Buy
- Analyst Count
- TTEK 5
- CORT 4
- Target Price
- TTEK $40.00
- CORT $142.00
- AVG Volume (30 Days)
- TTEK 2.7M
- CORT 1.2M
- Earning Date
- TTEK 05-07-2025
- CORT 05-05-2025
- Dividend Yield
- TTEK 0.74%
- CORT N/A
- EPS Growth
- TTEK N/A
- CORT 8.36
- EPS
- TTEK 0.69
- CORT 1.14
- Revenue
- TTEK $4,555,101,000.00
- CORT $685,446,000.00
- Revenue This Year
- TTEK $8.15
- CORT $35.85
- Revenue Next Year
- TTEK N/A
- CORT $35.22
- P/E Ratio
- TTEK $50.55
- CORT $67.89
- Revenue Growth
- TTEK 10.76
- CORT 30.93
- 52 Week Low
- TTEK $27.27
- CORT $28.04
- 52 Week High
- TTEK $51.20
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- TTEK 60.04
- CORT 59.56
- Support Level
- TTEK $34.78
- CORT $74.34
- Resistance Level
- TTEK $36.37
- CORT $80.65
- Average True Range (ATR)
- TTEK 0.76
- CORT 2.95
- MACD
- TTEK -0.11
- CORT 0.26
- Stochastic Oscillator
- TTEK 25.13
- CORT 73.79
About TTEK Tetra Tech Inc.
Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. Tetra Tech has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.